Prediction of outcome from MRI and general movements assessment after hypoxic-ischaemic encephalopathy in low-income and middle-income countries: data from a randomised controlled trial.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 01 12 2020
revised: 26 03 2021
accepted: 20 04 2021
pubmed: 12 6 2021
medline: 4 1 2022
entrez: 11 6 2021
Statut: ppublish

Résumé

To evaluate the accuracy of neonatal MRI and general movements assessment (GMA) in predicting neurodevelopmental outcomes in infants with hypoxic-ischaemic encephalopathy (HIE). Secondary analyses of a randomised controlled trial (RCT). Tertiary neonatal intensive care unit in India. Fifty infants with HIE were included in an RCT of therapeutic hypothermia (25 cooled and 25 non-cooled). All infants underwent brain MRI at day 5, GMA at 10-15 weeks and outcome assessments including Bayley Scales of Infant and Toddler Development, third edition, at 18 months. Associations between patterns of brain injury, presence/absence of fidgety movements (FMs) and outcomes were assessed. Seventeen of 47 (36%) had adverse outcome (5 (21%) cooled vs 12 (52%) non-cooled, p=0.025). Eight infants died (four before an MRI, another three before GMA). Two developed severe cerebral palsy and seven had Bayley-III motor/cognitive composite score <85. Twelve (26%) had moderately/severely abnormal MRI and nine (23%) had absent FMs. The positive predictive value (95% CI) of an adverse outcome was 89% (53% to 98%) for moderate/severe basal ganglia and thalami (BGT) injury, 83% (56% to 95%) for absent/equivocal signal in the posterior limb of the internal capsule (PLIC) and 67% (38% to 87%) for absent FMs. Negative predictive values (95% CI) were 85% (74% to 92%) for normal/mild BGT injury, 90% (78% to 96%) for normal PLIC and 86% (74% to 93%) for present FMs. Neonatal MRI and GMA predicted outcomes with high accuracy in infants with HIE. The GMA is a feasible low-cost method which can be used alone or complementary to MRI in low-resource settings to prognosticate and direct follow-up. CTRI/2013/05/003693.

Identifiants

pubmed: 34112719
pii: archdischild-2020-321309
doi: 10.1136/archdischild-2020-321309
pmc: PMC8685634
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-38

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: NT has a patent 1796/DEL/2013 Life cradle device for inducing neonatal hypothermia issued.

Références

Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F75-8
pubmed: 21068075
Int J Dev Neurosci. 2013 Nov;31(7):543-9
pubmed: 23831075
Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F398-404
pubmed: 23080477
J Pediatr. 2012 Nov;161(5):799-807
pubmed: 22682614
J Clin Med. 2019 Oct 25;8(11):
pubmed: 31717717
Arch Pediatr Adolesc Med. 2012 Jul 1;166(7):634-40
pubmed: 22751877
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Semin Fetal Neonatal Med. 2015 Apr;20(2):72-9
pubmed: 25457083
Pediatrics. 2008 May;121(5):906-14
pubmed: 18450893
Dev Med Child Neurol. 2013 Nov;55(11):1053-9
pubmed: 23927586
J Paediatr Child Health. 2020 Sep;56(9):1414-1418
pubmed: 32767642
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003311
pubmed: 23440789
PLoS One. 2014 Feb 05;9(2):e87874
pubmed: 24505327
Arch Pediatr Adolesc Med. 2010 Apr;164(4):352-6
pubmed: 20368488
Lancet Neurol. 2010 Jan;9(1):39-45
pubmed: 19896902
Am J Obstet Gynecol. 1999 Apr;180(4):1024-9
pubmed: 10203673
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Bull World Health Organ. 2005 Jun;83(6):409-17
pubmed: 15976891
Early Hum Dev. 2010 Nov;86(11):675-82
pubmed: 20864278
Dev Med Child Neurol. 2018 May;60(5):480-489
pubmed: 29468662
J Pediatr. 2011 Jun;158(6):904-11
pubmed: 21232764
Clin Neuropsychol. 2017 Feb;31(2):371-381
pubmed: 27687612
Semin Perinatol. 2003 Aug;27(4):320-32
pubmed: 14510323
Early Hum Dev. 2013 Oct;89(10):787-93
pubmed: 23850484
J Pediatr (Rio J). 2016 May-Jun;92(3 Suppl 1):S64-70
pubmed: 26997356
J Pediatr. 2005 Apr;146(4):453-60
pubmed: 15812446
Arch Dis Child Fetal Neonatal Ed. 2020 Jul;105(4):405-411
pubmed: 31662328
EClinicalMedicine. 2018 Dec;6:26-35
pubmed: 30740596
JAMA Pediatr. 2017 Sep 1;171(9):897-907
pubmed: 28715518
Pediatr Res. 2014 May;75(5):670-4
pubmed: 24492622
Pediatr Res. 2014 Jul;76(1):93-9
pubmed: 24713817
Pediatr Crit Care Med. 2013 Oct;14(8):786-95
pubmed: 23897243
Indian J Pediatr. 2021 Jan;88(1):28-33
pubmed: 32488806

Auteurs

Karoline Aker (K)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Faculty of Medicine and Health Sciences, Trondheim, Norway karoline.aker@ntnu.no.
Department of Paediatrics, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Niranjan Thomas (N)

Department of Neonatology, Christian Medical College Vellore, Vellore, Tamil Nadu, India.

Lars Adde (L)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Faculty of Medicine and Health Sciences, Trondheim, Norway.
Clinic of Clinical Services, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Beena Koshy (B)

Department of Developmental Paediatrics, Christian Medical College Vellore, Vellore, Tamil Nadu, India.

Miriam Martinez-Biarge (M)

Department of Paediatrics, Imperial College London, London, UK.

Ingeborg Nakken (I)

Norwegian Advisory Unit for Functional MRI, Department of Radiology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Caroline S Padankatti (CS)

Department of Developmental Paediatrics, Christian Medical College Vellore, Vellore, Tamil Nadu, India.

Ragnhild Støen (R)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Faculty of Medicine and Health Sciences, Trondheim, Norway.
Department of Paediatrics, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH